article thumbnail

Leveraging Sterile Compounding Technology and Removing Barriers to Improve Safety

Omnicell

And one of the highest areas of opportunity for human error is in the sterile compounding process. The guidelines recognize IV workflow management systems as the minimum safety standard for preparing compounded preparations and IV robotics are recommended for high volume, large batch preparations. savings per year.

article thumbnail

ASHP Midyear 2022: Partnering for Optimized Pharmacy Outcomes

Omnicell

Pharmacy experts will discuss results from the 2022 ISMP sterile compounding survey, which delves into the risks associated with compounding, current technologies in use, and compliance best practices.

article thumbnail

Omnicell Unveils Groundbreaking Robotic Compounding Technology in Winter 2022 Release

Omnicell

Dennis Wright Senior Director, Product Marketing, Omnicell For more than 15 years, IV robotics has proven efficacy in safe and efficient sterile compounding, but market adoption has been limited. A new era of IV robotics in the IVX Station , new technology introduced as part of Omnicell's Winter 2022 Release.